ASO Visual Abstract: Tumor-Infiltrating Lymphocytes (TILs) as a Biomarker of Abscopal Effect of Cryoablation in Breast Cancer-A Pilot Study

被引:1
|
作者
Khan, Sonia Y. [1 ]
Melkus, Michael W. [1 ]
Rasha, Fahmida [2 ]
Castro, Maribel [1 ]
Chu, Victoria [1 ]
Brandi, Luis [3 ]
Khan, Hafiz [4 ]
Gill, Harvinder Singh [5 ]
Pruitt, Kevin [2 ]
Rahman, Rakhshanda Layeequr [1 ,6 ]
机构
[1] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Dept Surg, Lubbock, TX 79430 USA
[2] Texas Tech Univ, Hlth Sci Ctr, Dept Immunol & Mol Microbiol, Lubbock, TX 79430 USA
[3] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Dept Pathol, Lubbock, TX 79430 USA
[4] Texas Tech Univ, Hlth Sci Ctr, Julia Jones Matthews Dept Publ Hlth, Lubbock, TX 79430 USA
[5] Texas Tech Univ, Dept Chem Engn, Lubbock, TX 79409 USA
[6] Texas Tech Univ, Hlth Sci Ctr, Breast Ctr Excellence, Lubbock, TX 79430 USA
关键词
D O I
10.1245/s10434-021-11240-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Morphological evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer is gaining momentum as an immunological biomarker. This experiment evaluates the role of TILs in distant tumors as a measure of abscopal effect from cryoablation of breast cancer. Methods: BALB/c mice underwent bilateral orthotopic transplant with 4T1-12B (triple-negative) cells. At 2 weeks, left tumors were treated by either resection (standard of care group) or cryoablation (intervention group) followed by resection of the distant right tumors 1 week posttreatment. TIL scores were calculated from hematoxylin and eosin-stained sections and phenotyped for cytotoxic T-lymphocyte (CTL) markers by immunofluorescence. Primarily resected tumors served as baseline (Tbaseline), whereas resected distant right-sided served as the readout for abscopal effect (AbsRes or AbsCryo). Mice were monitored for tumor recurrence and metastasis. Results: The AbsCryo had a significant mean (SD) increase in stromal (2.8 [1.1]%; p = 0.015) and invasive margin TILs (50 [12]%; p = 0.02) compared with TBaseline (1.0 [0]% and 31 [4.9]%, respectively). CTL phenotyping revealed a significant increase in mean (SD) CD8+ T cells (15.7 [12.1]; p = 0.02) and granzyme B (4.8 [3.6]; p = 0.048) for the AbsCryo compared with TBaseline (5.2 [4.7] and 2.4 [0.9], respectively). Posttreatment, the cryoablation group had no recurrence or metastasis, whereas the resected group showed local recurrence and lung metastasis in 40% of the mice. Postprocedure increase in TIL score of distant tumors was associated with decrease in tumor relapse (p = 0.02). Conclusions: Cryoablation induced a robust tumor-specific TIL response compared with resection, suggesting an abscopal effect leading to the prevention of cancer recurrence and metastasis. © 2022, The Author(s).
引用
收藏
页码:2928 / 2929
页数:2
相关论文
共 50 条
  • [1] Tumor-Infiltrating Lymphocytes (TILs) as a Biomarker of Abscopal Effect of Cryoablation in Breast Cancer: A Pilot Study
    Sonia Y. Khan
    Michael W. Melkus
    Fahmida Rasha
    Maribel Castro
    Victoria Chu
    Luis Brandi
    Hafiz Khan
    Harvinder Singh Gill
    Kevin Pruitt
    Rakhshanda Layeequr Rahman
    Annals of Surgical Oncology, 2022, 29 : 2914 - 2925
  • [2] ASO Visual Abstract: Is There a Relationship Between Tumor-Infiltrating Lymphocytes (TILs) and Regression in Melanoma?
    Steven Morrison
    Gang Han
    Faith Elenwa
    John Vetto
    Graham Fowler
    Stanley P. Leong
    Mohammed Kashani-Sabet
    Barbara Pockaj
    Heidi E. Kosiorek
    Jonathan S. Zager
    Jane L. Messina
    Nicola Mozzillo
    Schlomo Schneebaum
    Dale Han
    Annals of Surgical Oncology, 2022, 29 : 2869 - 2870
  • [3] ASO Visual Abstract: Is There a Relationship Between Tumor-Infiltrating Lymphocytes (TILs) and Regression in Melanoma?
    Morrison, Steven
    Han, Gang
    Elenwa, Faith
    Vetto, John
    Fowler, Graham
    Leong, Stanley P.
    Kashani-Sabet, Mohammed
    Pockaj, Barbara
    Kosiorek, Heidi E.
    Zager, Jonathan S.
    Messina, Jane L.
    Mozzillo, Nicola
    Schneebaum, Schlomo
    Han, Dale
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (05) : 2869 - 2870
  • [4] Prognostic impact of tumor-infiltrating lymphocytes (TILs) in male breast cancer
    Abdeljaoued, S.
    Bettaieb, I.
    Adouni, O.
    Goucha, A.
    El Amine, O.
    Chabchoub, A.
    Bouzaiene, H.
    Ben Hassouna, J.
    Makhlouf, R.
    Ben Dhiab, T.
    Boussen, H.
    Rahal, K.
    Gamoudi, A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [5] Tumor-Infiltrating Lymphocytes: A Promising Biomarker in Breast Cancer
    Heppner, Barbara Ingold
    Loibl, Sibylle
    Denkert, Carsten
    BREAST CARE, 2016, 11 (02) : 96 - 100
  • [6] Tumor Infiltrating Lymphocytes (TIL) as a Biomarker of Abscopal Effect After Cryoablation Versus Resection
    Khan, S. Y.
    Melkus, M. W.
    Chu, V.
    Brandi, L.
    Khan, H.
    Rahman, R. Layeequr
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S11 - S11
  • [7] Tumor infiltrating lymphocytes (TILs) as prognostic biomarker in patients with breast cancer
    Denkert, C.
    BREAST, 2021, 56 : S5 - S5
  • [8] Antitumor reactivity of human breast tumor-infiltrating lymphocytes (TILs).
    Lee, Heejae
    Kim, Young-Ae
    Park, Hye Seon
    Bang, Won Seon
    Park, In Ah
    Lee, Miseon
    Gong, Gyungyub
    Lee, Hee Jin
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (04) : 58 - 59
  • [9] The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
    Salgado, R.
    Denkert, C.
    Demaria, S.
    Sirtaine, N.
    Klauschen, F.
    Pruneri, G.
    Wienert, S.
    Van den Eynden, G.
    Baehner, F. L.
    Penault-Llorca, F.
    Perez, E. A.
    Thompson, E. A.
    Symmans, W. F.
    Richardson, A. L.
    Brock, J.
    Criscitiello, C.
    Bailey, H.
    Ignatiadis, M.
    Floris, G.
    Sparano, J.
    Kos, Z.
    Nielsen, T.
    Rimm, D. L.
    Allison, K. H.
    Reis-Filho, J. S.
    Loibl, S.
    Sotiriou, C.
    Viale, G.
    Badve, S.
    Adams, S.
    Willard-Gallo, K.
    Loi, S.
    ANNALS OF ONCOLOGY, 2015, 26 (02) : 259 - 271
  • [10] Tumor-infiltrating lymphocytes (TILs) in ER+/HER2-breast cancer
    Criscitiello, C.
    Vingiani, A.
    Maisonneuve, P.
    Viale, G.
    Vialel, G.
    Curigliano, G.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 183 (02) : 347 - 354